DENVER, Aug. 23, 2022 (GLOBE NEWSWIRE) — Asur Holdings Corporation (the “Company” or “prove it”) (NASDAQ: IONM ), a provider of surgical neuromonitoring (“IONM”) and remote neurology services, announced the appointment of Robin Sweet to vice president, strategic accounts.
Prior to joining Ashur, Ms. Sweet worked at Premier Inc. She served as the director of a group buying firm (“GPO”) for the sale of national accounts. Prior to that, Ms. Sweet served as Vice President of Sales at Health Trust, where her efforts contributed to more than $100 million in corporate revenue. Ms. Sweet earned a Bachelor of Science in Nursing from the University of Texas Health Science Center.
“We are excited to have Robyn join our team and lead Assure’s efforts to build new business development opportunities with our GPO partners. Robin has twelve years of experience working for national healthcare GPOs, including Premier, Health Trust and AmeriNet, bringing valuable domain knowledge, expertise and contacts that were not previously secured,” said John A. Farlinger, Assur Executive Chairman and CEO. “Robin’s hiring reflects Assure’s 2022 strategy of continuing to focus our business on GPO and facility-based contracts.”
On her appointment, Ms. Sweet commented, “Safety, service and improved clinical outcomes are at the core of Asur’s mission and the main drivers of the company’s growth. I look forward to hitting the ground running and making an impact in the organization.”
About Acer Holdings
Asur Holdings Corporation is an outsourced provider of internal surgery and remote neurology services providing best-in-class services. The company provides clinical and operational services to support surgeons and medical facilities in invasive procedures involving the nervous system, including neurosurgery, spine, cardiovascular, orthopedic and ear, nose and throat surgery. Acer employs highly trained technologists who provide a direct point of contact in the operating room. Physicians employed by Assure affiliates monitor the functional integrity of patients’ neural structures in real-time communication with the surgeon and technologist throughout the procedure. Accredited by The Joint Commission, Assure’s mission is to provide exceptional surgical care and a positive patient experience. For more information, visit the company’s website at www.assureneuromonitoring.com.
Forward-looking statements
This news release may contain “forward-looking statements” within the meaning of applicable securities laws, including, but not limited to, statements regarding the Company’s growth and development and expectations regarding future service quality and results. Forward-looking statements can generally be identified by the words “expects,” “expects,” “intends,” “plans,” “will,” “could,” “could,” “could,” “will.” “believes,” “estimates,” “potential,” “target” or “continue” and variations or similar statements. These statements are based on management’s current expectations and beliefs and are subject to certain risks and uncertainties that could cause actual results to differ materially from those expressed in forward-looking statements. These risks and uncertainties include, but are not limited to: the uncertainty surrounding the spread of COVID-19 and its impact on the Company’s operations and business, its remote neuroscience business and its general economic activity; Risks and uncertainties discussed in our most recent annual and quarterly reports filed with the United States Securities and Exchange Commission, including our Annual Report on Form 10-K filed on March 14, 2022 and in the Company’s EDGAR profile at www.sec.gov, which risks and uncertainties They are included here. Except as required by law, Asur does not intend and undertakes no obligation to update any forward-looking statements, particularly as a result of new information or future events.
Connect
Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
(720) 617-2526
Scott.Kozak@assureiom.com
